J Korean Neuropsychiatr Assoc.  1999 Nov;38(6):1469-1478.

Acute Effects of Paroxetine and Amitriptyline on the Psychomotor Performancein Healthy Volunteers

Affiliations
  • 1Department of Psychiatry, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
  • 2Department of Psychiatry, Hanil Hospital, Seoul, Korea.
  • 3Department of Psychiatry, Ulsan University Hospital, Ulsan, Korea.

Abstract


OBJECTIVES
Paroxetine is known to have fewer cognitive side effects than older antidepressants such as amitriptyline. To confirm this objectively, we compared the effects of paroxetine on the psychomotor performance with those of amitriptyline in 10 healthy volunteers. METHOD: Paroxetine and amitriptyline were administered orally in a double-blind, two-way, single dose, crossover design. Assessments of psychomotor performances were carried out before and 2 and 6 hours after administration of single dose of paroxetine (40mg) or amitriptyline (50mg). Each treatment day was separated by 1 week of washout period. The psychomotor performances were measured using Vienna Determination Unit, Vienna Reaction Time, Vienna Signal Detection, Grooved Pegboard Test and Finger Tapping Test. The data were analyzed using two-way, repeated measures ANOVA on a crossover model.
RESULTS
The results showed that paroxetine 40mg produced no significant performance decrements on the every test of psychomotor performances, whereas amitriptyline 50mg produced markedly impaired performance on most of the psychomotor tests.
CONCLUSION
This study confirmed pervious findings that paroxetine is generally devoid of adverse side effects on psychomotor performance.

Keyword

SSRI; Paroxetine; Amitriptyline; Psychomotor performance

MeSH Terms

Amitriptyline*
Antidepressive Agents
Cross-Over Studies
Fingers
Healthy Volunteers*
Paroxetine*
Psychomotor Performance
Reaction Time
Amitriptyline
Antidepressive Agents
Paroxetine
Full Text Links
  • JKNA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr